Author/Authors :
Ghanbari Zinat نويسنده Department of Pelvic Floor, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. , Zebardast Jayran نويسنده Deputy of Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran , Salimi Samrand نويسنده Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran. Salimi Samrand , Foroughifar Tahereh نويسنده Female Pelvic Floor Department, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran , Tootoonchi Saman نويسنده Department of Psychiatry, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran , Shabihkhani Sara نويسنده Department of Gynecology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran , Mokhtari Garakani Mahnaz نويسنده Department of Gynecology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran , Forooghifar Tayebeh نويسنده Department of Science and Research, Rudehen Branch, Islamic Azad University, Tehran, Iran
Abstract :
Background
It seems that some herbal medicines such as sage or vitagnus traditionally used as treatment agents are effective on menopausal symptoms such as hot flashes; therefore, the current study aimed at assessing the effect of vitagnus on menopausal symptoms.
Methods
The current study was a prospective clinical trial conducted on 100 menopausal patients divided into 3 groups. In each group, hot flash was treated with vitagnus, sage, or placebo pills and patients were followed-up at the days 15 and 30 after the treatment. The data were analyzed by descriptive (percentage, mean, and standard deviation) and inferential (chi-square, t-test, McNamara, repeated ANOVA) statistics with SPSS software, version 21 (IBM SPSS, Armonk, NY, USA).
Results
Average of hot flash in vitagnus group was 55.19 ± 14.53; it was also 60.26 ± 14.44 and 60.73 ± 12.30 in the sage and control groups. According to the Cooperman questionnaire score, comparison of hot flash data showed no significant difference between the groups before treatment (the Cooperman questionnaire score < 14) (P = 0.894), (15 - 20) (P = 0.262), (21 - 35) (P = 0.800), (35 < the Cooperman questionnaire score) (P = 0.867). The current study analysis showed no significant difference between the groups in the severity of menopause symptoms at 15-day follow-up (the Cooperman questionnaire score < 14) (P = 0.477), (the Cooperman’s questionnaire score 15 to 20) (P = 0.620), (the Cooperman questionnaire score 21 to 35) (P = 0.243), (35 < the Cooperman questionnaire score) (P = 0.278). But, the severity of menopause symptoms at 30-day follow-up showed significant differences between the groups, except between 15 - 20 and 21 - 35 scores (the Cooperman questionnaire score < 14) (P = 0.306), (15 - 20) (P = 0.005), (21 - 35) (P = 0.007), (35 < the Cooperman questionnaire score) (P = 0.785).
Conclusions
The results of the current study showed that vitagnus and sage were effective on the reduction of menopausal symptoms in postmenopausal females. The effect of placebo on the improvement of menopausal symptoms was significant and it is recommended to be used as an agent to reduce the psychological outcomes of menopause.
